Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
The safety profile at doses below those studied in clinical trials is not well characterized, and there is no FDA approval for this indication
FASEB J 10, 709720 (1996)
BDNF levels, a neurotrophic factor critical for neuronal survival and plasticity, were significantly decreased in the PPAS group (7.5 0.8 pg/mg protein) compared to the control group (14.1 1.6
Marzioni M, Alpini G, Saccomanno S, Candelaresi C, Venter J, Rychlicki C, et al
Quality sourcing and appropriate protocols minimize but do not eliminate potential risks
A part of the subjects from each study group were further analysed by phototrichography, in order to measure the number of anagen and telogen hairs
US$ 21.24
US$ 20.21
US$ 20.80
US$ 29.39
US$ 28.05
